BMRN vs EXC · P/E 40, rev $1.76B vs P/E 17, rev $24.26B
Biomarin Pharmaceutical Inc (BMRN) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the BMRN and EXC stock pages for the full models.
Not investment advice.